RecoMed: A Knowledge-Aware Recommender System for Hypertension Medications

• URL: http://arxiv.org/abs/2201.05461v1
• Date: Sun, 9 Jan 2022 08:01:41 GMT
• Title: RecoMed: A Knowledge-Aware Recommender System for Hypertension Medications
• Authors: Maryam Sajde, Hamed Malek, Mehran Mohsenzadeh
• Abstract summary: This paper aims to develop a medicine recommender system called RecoMed to aid the physician in the prescription process of hypertension. A list of recommended medicines is provided as the system's output, and physicians can choose one or more of the medicines based on the patient's clinical symptoms.
• Score: 1.2633386045916444
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Background and Objective High medicine diversity has always been a significant challenge for prescription, causing confusion or doubt in physicians' decision-making process. This paper aims to develop a medicine recommender system called RecoMed to aid the physician in the prescription process of hypertension by providing information about what medications have been prescribed by other doctors and figuring out what other medicines can be recommended in addition to the one in question. Methods There are two steps to the developed method: First, association rule mining algorithms are employed to find medicine association rules. The second step entails graph mining and clustering to present an enriched recommendation via ATC code, which itself comprises several steps. First, the initial graph is constructed from historical prescription data. Then, data pruning is performed in the second step, after which the medicines with a high repetition rate are removed at the discretion of a general medical practitioner. Next, the medicines are matched to a well-known medicine classification system called the ATC code to provide an enriched recommendation. And finally, the DBSCAN and Louvain algorithms cluster medicines in the final step. Results A list of recommended medicines is provided as the system's output, and physicians can choose one or more of the medicines based on the patient's clinical symptoms. Only the medicines of class 2, related to high blood pressure medications, are used to assess the system's performance. The results obtained from this system have been reviewed and confirmed by an expert in this field.

Related papers

• A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management [3.8243906257653504]
  We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial.
  arXiv  Detail & Related papers  (2024-09-03T13:50:59Z)
• Leave No Patient Behind: Enhancing Medication Recommendation for Rare Disease Patients [47.68396964741116]
  We propose a novel model called Robust and Accurate REcommendations for Medication (RAREMed) to enhance accuracy for rare diseases. It employs a transformer encoder with a unified input sequence approach to capture complex relationships among disease and procedure codes. It provides accurate drug sets for both rare and common disease patients, thereby mitigating unfairness in medication recommendation systems.
  arXiv  Detail & Related papers  (2024-03-26T14:36:22Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• Conditional Generation Net for Medication Recommendation [73.09366442098339]
  Medication recommendation targets to provide a proper set of medicines according to patients' diagnoses, which is a critical task in clinics. We propose Conditional Generation Net (COGNet) which introduces a novel copy-or-predict mechanism to generate the set of medicines. We validate the proposed model on the public MIMIC data set, and the experimental results show that the proposed model can outperform state-of-the-art approaches.
  arXiv  Detail & Related papers  (2022-02-14T10:16:41Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)
• SafeDrug: Dual Molecular Graph Encoders for Safe Drug Recommendations [59.590084937600764]
  We propose a DDI-controllable drug recommendation model named SafeDrug to leverage drugs' molecule structures and model DDIs explicitly. On a benchmark dataset, our SafeDrug is relatively shown to reduce DDI by 19.43% and improves 2.88% on Jaccard similarity between recommended and actually prescribed drug combinations over previous approaches.
  arXiv  Detail & Related papers  (2021-05-05T00:20:48Z)
• An Analysis of a BERT Deep Learning Strategy on a Technology Assisted Review Task [91.3755431537592]
  Document screening is a central task within Evidenced Based Medicine. I propose a DL document classification approach with BERT or PubMedBERT embeddings and a DL similarity search path. I test and evaluate the retrieval effectiveness of my DL strategy on the 2017 and 2018 CLEF eHealth collections.
  arXiv  Detail & Related papers  (2021-04-16T19:45:27Z)
• PREMIER: Personalized REcommendation for Medical prescrIptions from Electronic Records [8.365167718547296]
  We design a two-stage attention-based personalized medication recommender system called PREMIER. Our system takes into account the interactions among drugs in order to minimize the adverse effects for the patient. Experiment results on MIMIC-III and a proprietary outpatient dataset show that PREMIER outperforms state-of-the-art medication recommendation systems.
  arXiv  Detail & Related papers  (2020-08-28T04:48:32Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.